Montevideo, 02/05/2022- The questions and answers (Q&As) that you can download below are based on the most recent interim recommendations from the WHO Strategic Advisory Group of Experts on Immunization (SAGE) for COVID-19 vaccines that have been approved by WHO under Emergency Use Listing (EUL)a as of 15 February 2022 ((Pfizer–BioNTech BNT162b2, Moderna mRNA-1273, AstraZeneca AZD1222 Vaxzevria™, SII COVISHIELD™ ChAdOx1-S [recombinant], Janssen Ad26.COV2.S, Sinopharm BIBP, Sinovac CoronaVac, Bharat Biotech BBV152 COVAXIN®, Novavax NVX-Co2373).
The Q&As are intended to provide answers to health providers and the public on COVID-19 vaccination during pregnancy.
